Minaris Advanced Testing Capabilities Update March 2026: Analytical Services

Minaris Advanced Testing provides comprehensive multimodality biosafety testing services designed to support the development, optimization, and commercialization of biologics as well as cell and gene therapy products. Their service portfolio includes viral clearance studies, a full suite of biosafety testing assays, detailed product characterization, and GMP-compliant analytical services. These capabilities enable sponsors to generate the high‑quality data required to meet regulatory expectations and advance programs confidently from early development through commercial readiness.

With a client‑first philosophy, Minaris Advanced Testing emphasizes collaboration, transparency, and efficiency throughout every engagement. Their scientific and operational teams work closely with sponsors to design tailored testing strategies, reduce study timelines, and deliver cost‑effective solutions without compromising data integrity. By integrating technical expertise with streamlined processes and responsive communication, Minaris Advanced Testing creates a smooth, dependable experience that helps innovators accelerate decision‑making, mitigate risk, and successfully progress their therapeutic programs toward market approval.